Serial Changes in Circulating Platelet Activation and Platelet Aggregation after Carotid Artery Stenting

LIU Fang,WANG Da-ming,LIU Jia-chun,LI Jin,XU Xiao-dong,HAO Hong-jun,HUANG Yi-ning
DOI: https://doi.org/10.3969/j.issn.1009-6213.2008.02.003
2008-01-01
Abstract:ObjectiveWe investigated serial changes of circulation platelet activation markers in vivo and platelet aggregation function in vitro in patients undergoing carotid artery stenting(CAS) within 1 week.MethodsThe platelet-monocyte aggregates and fibrinogen receptors analyzed by flow cytometric and platelet aggregation tests using Born's method as well as serum soluble CD 40 ligand and soluble P-selectin quantified by enzyme-linked immunosorbent assay were determined in twenty patients with symptomatic carotid stenosis undergoing CAS.Blood samples were obtained immediately before stent implantation and 0.5 h,18 h,6 d after the procedure respectively.All twenty patients were on dual antiplatelet therapy of aspirin and clopidogrel before CAS,and all patients were stented with embolic protection devices.ResultsSoluble CD 40 ligand levels increased from 0.8(0.23~2.38)ng/ml before procedure to 2.35(1.14~5.38)ng/ml,4.10(2.27~6.91)ng/ml at 18 h and 6 d after the procedure respectively(P0.05).Similary,soluble P-selectin levels increased from 54.46±28.53 ng/ml before procedure to 73.03±35.4 ng/ml at 6 d after the procedure(P0.05).Circulation platelet-monocyte aggregates,fibrinogen receptors and the maximum platelet aggregation rate,however,were not changed after the procedure.ConclusionElevated serum soluble CD 40 ligand and soluble P-selectin levels indicate the occurrence of platelet activation after CAS,despite treatment with dual antiplatelet therapy before CAS and the application of embolic protection devices during the procedure.
What problem does this paper attempt to address?